Skip to content

Open Facet Joint Denervation in the Treatment of Low Back Pain

Open Facet Joint Denervation in the Treatment of Low Back Pain -A Randomized Control Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03487120
Enrollment
60
Registered
2018-04-03
Start date
2016-04-26
Completion date
2017-04-11
Last updated
2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain

Brief summary

A single blinded RCT for adult patients with spine pain. One group had a lumbar laminectomy with denervation of the facet joint at the level decompressed. The other group had a lumbar laminectomy without facet joint denervation. Both groups had their back pain and functional limitations measured using a 10 cm visual analogue scale and the Oswestry disability index (ODI). All measures were taken before surgery and at patients' 6, 12 and 24 week follow-up clinic visit.

Interventions

PROCEDUREfacet joint denervation

Bipolar electrocautery

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 19 or older * a diagnosis of spinal stenosis * having neurogenic claudication * complained of back pain for at least 3 months

Exclusion criteria

* previous surgery on their spine, * fracture, systemic inflammatory disease, * malignancies or an infection affecting their spine

Design outcomes

Primary

MeasureTime frameDescription
Change in Visual analog scale for pain (VAS)change from baseline score at 24 weeks10 centimeter scale with a minimum of 0 indicating no pain and a maximum of 10 indicating worst pain.

Secondary

MeasureTime frameDescription
Change in Modified Oswestry Disability score (ODI)change from baseline score at 24 weeksThe ODI is divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale. The range of scores is 0 to a maximum of 60. The total score is multiplied by 2 and expressed as a percentage. A score of 0 to 20 points indicates minimal disability; 20 to 40 points, moderate disability; and 40 to 60 points, severe disability.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026